{"id":35411,"date":"2025-04-19T02:36:08","date_gmt":"2025-04-19T02:36:08","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/35411\/"},"modified":"2025-04-19T02:36:08","modified_gmt":"2025-04-19T02:36:08","slug":"un-chercheur-francais-recompense-pour-son-approche-curative-revolutionnaire-contre-le-cancer","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/35411\/","title":{"rendered":"Un chercheur fran\u00e7ais r\u00e9compens\u00e9 pour son approche curative \u00abr\u00e9volutionnaire\u00bb contre le cancer"},"content":{"rendered":"

Le prix L\u00e9opold-Griffuel distingue chaque ann\u00e9e un scientifique pour l\u2019ensemble de sa carri\u00e8re.
\n catalin – stock.adobe.com<\/p>\n

ENTRETIEN<\/strong> –<\/strong> Le professeur en immunologie \u00c9ric Vivier a re\u00e7u le prix L\u00e9opold-Griffuel de la Fondation ARC pour son traitement anticanc\u00e9reux utilisant des lymphocytes particuliers, appel\u00e9s \u00ab\u00a0natural killer\u00a0\u00bb, qui peuvent agir sur de nombreux types de tumeurs.<\/p>\n

La\u00a0Fondation ARC<\/a>\u00a0(Aide \u00e0 la recherche sur le cancer) a r\u00e9compens\u00e9 cette semaine six chercheurs pour leurs travaux, dont le Pr\u00a0\u00c9ric Vivier, qui dirige le laboratoire \u00ab\u00a0Cellules inn\u00e9es lympho\u00efdes\u00a0\u00bb au Centre d\u2019immunologie<\/a>\u00a0de Marseille-Luminy. Ce dernier a re\u00e7u le prestigieux prix L\u00e9opold-Griffuel de recherche translationnelle et clinique, assorti d\u2019un ch\u00e8que de 150.000\u20ac, qui distingue chaque ann\u00e9e un scientifique pour l\u2019ensemble de sa carri\u00e8re. Depuis 1995, \u00c9ric Vivier d\u00e9veloppe une approche curative originale exploitant l\u2019immunit\u00e9 inn\u00e9e.<\/p>\n

LE FIGARO. – Vous pr\u00e9sentez votre approche comme r\u00e9volutionnaire. Pourquoi\u00a0?<\/strong><\/p>\n

\u00c9ric VIVIER. –<\/strong> La plupart des\u00a0traitements anticanc\u00e9reux<\/a>\u00a0ciblent directement la tumeur en s\u2019attaquant aux cellules responsables de son d\u00e9veloppement. Notre approche, \u00e0 l\u2019inverse, consiste \u00e0 mobiliser le syst\u00e8me immunitaire des malades. Pour cela, il y a deux d\u00e9marches possibles\u00a0: soit viser les cellules du syst\u00e8me immunitaire, comme les lymphocytes T. Ces cellules font\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 82% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vous avez envie de lire la suite ?<\/p>\n

D\u00e9bloquez tous les articles imm\u00e9diatement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"Le prix L\u00e9opold-Griffuel distingue chaque ann\u00e9e un scientifique pour l\u2019ensemble de sa carri\u00e8re. catalin – stock.adobe.com ENTRETIEN –…\n","protected":false},"author":2,"featured_media":35412,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[237,101,232,231,234,228,1011,27,72,239,230,238,226,224,225,233,229,236,235,71,227],"class_list":{"0":"post-35411","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-fr","15":"tag-france","16":"tag-health","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-obesite","24":"tag-pathologie","25":"tag-pediatrie","26":"tag-psychiatrie","27":"tag-sante","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114362304689494759","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/35411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=35411"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/35411\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/35412"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=35411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=35411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=35411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}